SBS Code
stringlengths 9
11
| SBS Code (Hyphenated)
stringlengths 11
12
| Short Description
stringlengths 3
74
| Long Description
stringlengths 7
544
| Chapter
float64 1
25
⌀ | Chapter Name
stringclasses 25
values | Block
int64 1
4.02k
| Block Name
stringlengths 3
99
⌀ | Definition
stringlengths 11
1.18k
⌀ | Includes
stringlengths 4
1.31k
⌀ | Excludes
stringlengths 1
1.23k
⌀ | Guidelines
stringlengths 1
1.54k
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
732000990 | 73200-09-90 | Tissue Protein | Protein tissue analysis (e.g. muscle) by Western Blot with interoperation and report | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Western blot protein analysis of muscle tissue (e.g. muscular dystrophy) | null | null | null |
732001000 | 73200-10-00 | Tissue Protein probe | Protein tissue analysis (e.g. muscle) by Western Blot using immunological probes for band identification with interpretation and report | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Western blot protein analysis of skin tissue (e.g. Pompe disease) | null | null | null |
732001010 | 73200-10-10 | Morphometric ISH; Man Multplx probe Stain; Quant/SemiQuant | Quantitative/Semiquantitative In situ hybridization (ISH) by multiplex single probe stain on tissue | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Additional morphometric manual ISH testing by multiplex probes for detection and characterization of tumors (e.g. breast or cervical cancers) | null | null | Assign this code for each multiplex probe stain of each specimen. Do not report this code with (73200-09-60, Morphometric ISH; Computerized Single Probe Stain, Morphometric ISH; Computerized Multiplex Stain, 73200-09-80) for the same probe |
732001020 | 73200-10-20 | Laser capture microdissection | Tissue specimen preparation by laser capture method | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Isolation of tissue cells under microscope with the help of laser | null | null | Do not assign this code with (73200-10-30; Manual Microdissection) |
732001030 | 73200-10-30 | Manual microdissection | Manual specimen preparation | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Manual preparation of tissue under microscope to obtain pure cell samples for molecular analysis. | null | null | Do not assign this code with (73200-10-20; Laser Capture Microdissection) |
732001040 | 73200-10-40 | Tissue microdissection | Examination, dissection and preparation of tissue for non microscopic analysis (e.g. nucleic Acid-based molecular studyies) | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Tissue examination, dissection and preparation for nonmicroscopic analysis. | null | null | Assign this code for each tissue preparation (e.g. a single lymph node). Do not assign this code with (73200-10-50, 73200-07-80 to 73200-08-20) or for (microbiology cultures tissue preparation or flow cytometry studyies) |
732001050 | 73200-10-50 | Special macroscopic Dissection | Examination, dissection and preparation of tissue for non microscopic analysis with touch imprint cytology (TIC) analysis, intraoperative (IO), frozen section consultation | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Tissue examination, dissection and preparation for nonmicroscopic analysis including touch imprint, intraoperative consultation or frozen section. | null | null | This is an additional code to be assigned with (73200-07-80 to 73200-08-20). Do not assign this code for (microbiology cultures tissue preparation or flow cytometry studyies). Do not assign this code alone. |
732001060 | 73200-10-60 | Unlist surg pathology proc | Unlisted surgical pathology procedure (histo-diagnostic procedure) | 21 | Laboratory and Pathology | 3,200 | Cell study - Disease Analysis & Genetics; Specimen study | Unlisted or unspecified surgical pathology procedure | null | null | null |
732500091 | 73250-00-91 | Blood group + Rh | Blood Grouping, Rhesus (Rh) factor | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Classification of blood | null | null | null |
732500092 | 73250-00-92 | Blood typing; ABO & Rh (D) | Blood Typing utilizing ABO and Rh (D) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Classification of blood | null | null | null |
732500000 | 73250-00-00 | RBC Ab Screen for Donor | Screening for presence antibodies to red blood cells (RBC) or rhesus D (RhD) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Detection of antibodies to RBC antigens by various methods (e.g. indirect Coombs test, RBC agglutination test) to find donor for patients in needs of blood transfusion or to detect anti-Rh during pregnancy. Positive screen indicate presence of RBC however, it does not specify the exact antibodies | null | null | Assign this code for each RBC screening technique used |
732500010 | 73250-00-10 | R/O RBC bound abs | Removal of RBC bound antibodies | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Wash out or RBC bound antibodies (e.g. autoimmune hemolytic anemia) | null | null | Assign this code for each antibody elution |
732500020 | 73250-00-20 | Ab identification | Identification of specific antibodies to red blood cells (RBC) or rhesus D (RhD) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | A Follow up test after a positive RBC antibody screen to specify exacy RBC antibodies | null | null | Assign this code for each RBC panels or each RBC testing technique |
732500030 | 73250-00-30 | Direct coombs test | Direct antihuman globulin test (DAT) for identification of red blood cells antibodies | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Direct Coombs test (e.g. to identify hemolytic disease of newborn, i.e RhD incompatibility, igG, or for transfusion reactions). | null | null | Assign this code for each antiserum used |
732500040 | 73250-00-40 | Indirect coombs test | Qualitative indirect antihuman globulin test for identification of red blood cells antibodies | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Indirect Coombs test (e.g. to identify hemolytic disease of newborn, i.e RhD incompatibility, igG, or for transfusion reactions). | null | null | Assign this code for each Reagent Red Blood Cells used |
732500050 | 73250-00-50 | Indirect coombs test; titer | Qualitative indirect antihuman globulin test for identification of red blood cells antibodies using serial dilutions | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Indirect Coombs test in titer (e.g. to identify hemolytic disease of newborn, i.e RhD incompatibility, igG, or for transfusion reactions). | null | null | Assign this code for each antibody titer |
732500060 | 73250-00-60 | Predeposit autologous Blood | Collection, processing, and storage of autologous blood for future use | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Blood collection and storage of autologous donated blood for future transfusion (e.g. patients expecting future surgery) | null | null | null |
732500070 | 73250-00-70 | Intraoperative blood salvage (IBS) | Collection of lost blood during surgery for later intraoperative or postoperative infusion | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Autologous blood transfusion to recover blood lost during surgery for later infusion to patient | null | null | null |
732500080 | 73250-00-80 | ABO blood typing | Blood grouping (ABO) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test to determine patient serum plasma blood type by ABO blood group system | null | null | null |
732500090 | 73250-00-90 | Rh(D) typing | Blood grouping for Rhesus (Rh) factor | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test to determine patient serum blood type within the Rh blood group system. | null | null | Typically requested in addition to blood grouping (73250-00-80) |
732500100 | 73250-01-00 | Donor Blood Ag test; Reagent Serum | Antigen test to screen for potential donor blood using reagent serum | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Determination of blood transfusion compatibility | null | null | Assign this code for each tested antigen of each blood unit |
732500110 | 73250-01-10 | Donor Blood Ag test; Patient Serum | Antigen test to screen for potential donor blood using serum | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Determination of blood transfusion compatibility | null | null | Assign this code for each blood unit screened |
732500120 | 73250-01-20 | Other blood typing | Blood grouping for antigen other than ABO or RhD | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test to determine patient serum plasma blood type by other blood grouping systems | null | null | Assign this code for each tested antigen |
732500130 | 73250-01-30 | Complete Rh Phenotyping | Blood typing for the complete Rh phenotype | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test for donor transfusion compatibility or maternal immunization with antiRhD (to prevent fetal RBCs antibodies) | null | null | Typically requested in addition to blood grouping (73250-00-80) |
732500140 | 73250-01-40 | Paternity Blood Typing; ABO MN Rh | Blood typing using antigen systems ABO, MN, and Rh for paternity testing | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test for likelihood of paternity by ABO, MN, and Rh antigen systems | null | null | Assign this code for each individual tested |
732500150 | 73250-01-50 | Paternity Blood Typing; Other | Blood typing using other antigen systems for paternity testing | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Test for likelihood of paternity by antigen systems other than ABO, MN, and Rh | null | null | Assign this code for each other antigen system |
732500160 | 73250-01-60 | Cross Matching; Immediate spin | Crossmatch by immediate spin technique | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Testing for potential donor compatibility | null | null | Assign this code for each potential donor blood unit |
732500170 | 73250-01-70 | Cross Matching; Incubation | Crossmatch by incubation technique | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Testing for potential donor compatibility | null | null | Assign this code for each potential donor blood unit |
732500180 | 73250-01-80 | Cross Matching; Antiglobulin | Crossmatch by antiglobulin technique | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Testing for potential donor compatibility using antibodies | null | null | Assign this code for each potential donor blood unit |
732500190 | 73250-01-90 | Cross Matching; Electronic | Crossmatch by Laboratory Information System (LIS) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Testing for potential donor compatibility by comparing patient and donor electronic records for to verify ABO, Rh, and others (not a physical laboratory procedure) | null | null | Assign this code for each potential donor blood unit. Do not document this code in addition to crossmatch codes |
732500200 | 73250-02-00 | Thawing Fresh Frozen Plasma | Thawing of fresh frozen plasma unit | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Thawing of frozen plasma for treating certain conditions (e.g. coagulation factor deficiency) . | null | null | Assign this code for each thawed plasma unit. |
732500210 | 73250-02-10 | Blood Freezing | Preparation and freezing of blood | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Freezing blood for future thawing to be used in transfusions | null | null | Assign this code for each frozen blood unit. |
732500220 | 73250-02-20 | Thawing Frozen Blood | Thawing of frozen blood | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Thawing blood for transfusion | null | null | Assign this code for each thawed blood unit. |
732500230 | 73250-02-30 | Blood Freezing & Thawing | Preparation and freezing of blood with thawing | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Preparation, freezing, and thawing of blood | null | null | Assign this code for each prepared, frozen, and thawed blood unit. |
732500240 | 73250-02-40 | Hemolysin & Agglutinin | Blood screening for auto-agglutinins and auto-hemolysins | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Screening for auto–agglutinins and auto–hemolysins factors which induce blood cells clumping and rupture. | null | null | null |
732500250 | 73250-02-50 | Hemolysin & Agglutinin; Incubated | Blood screening for auto-agglutinins and auto-hemolysins by incubation method | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Screening for auto–agglutinins and auto–hemolysins factors which induce blood cells clumping and rupture. | null | null | null |
732500260 | 73250-02-60 | IrradiationBlood | Blood treatment with radiation | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Irradiation of donated blood before transfusion (e.g. gamma radiation, severely immunocompromised transfusion patients) | null | null | Assign this code for each irradiated blood unit. |
732500270 | 73250-02-70 | Leukocyte Transfusion | Transfusion of Leukocytes | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Separation of white blood cells from donor blood followed by transfusion to a recipient patient (e.g. low white blood count patient) | null | null | Do not assign this code for lymphocyte infusions or leukapheresis. |
732500280 | 73250-02-80 | Blood Volume reduct | Plasma removal from blood or blood products | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Removal of specific plasma component (e.g. ABO abs to recipient blood) in order to reduce transfusion reactions as hemolysis | null | null | Assign this code for each blood unit. |
732500290 | 73250-02-90 | Pooled platelets | Pooling and concentrating platelets or other blood products | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Platelet pooling | null | null | Assign this code for each drug or chemical used to treat RBCs before testing |
732500300 | 73250-03-00 | RBC PreTx w/ Chemical Drug | Incubation of red blood cells (RBCs) with a chemical agent or drug | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | RBC pretreatment with Chemical/drug incubation for test preparation (e.g. compatibility testing) | null | null | Assign this code for each enzyme used to treat RBCs before testing |
732500310 | 73250-03-10 | RBC PreTx w/ Enzymes | Incubation of red blood cells (RBCs) with an enzyme | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | RBC pretreatment with enzyme incubation for test preparation (e.g. compatibility testing, RBC Abs) | null | null | Assign this code for each drug used to treat serum before testing |
732500320 | 73250-03-20 | RBC PreTx w/ Density Gradient | Separation of red blood cells (RBCs) by density gradient method | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | RBC pretreatment with density gradient separation for test preparation (e.g. compatibility testing, RBC Abs) | null | null | null |
732500330 | 73250-03-30 | RBC PreTx w/ Drug | Incubation of red blood cells (RBCs) with drugs | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | RBC pretreatment with drug for test preparation (e.g. compatibility testing, RBC Abs) | null | null | null |
732500340 | 73250-03-40 | RBC PreTx w/ Dilution | Diluted sample preparation for identification of Red Blood Celss (RBC) antibodies | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | RBC dilution pretreatment for test preparation (e.g. compatibility testing, RBC Abs) | null | null | null |
732500350 | 73250-03-50 | RBC PreTx w/ Inhibitors | Incubation of red blood cells (RBCs) with inhibitors | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Red blood cells pretreatment with inhibitors for RBC Ab identification (e.g. Blood transfusion preparation) | null | null | Assign this code for each inhibitor used to treat serum before testing |
732500360 | 73250-03-60 | RBC PreTx w/ Serum | Serum preparation for RBC antibody testing | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Serum preparation/pretreatment for RBC antibody testing for identification of different serum antibodies. | null | null | null |
732500370 | 73250-03-70 | Split blood or products | Blood or blood products splitting | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Division of blood or blood products with storage (e.g. performed when partial blood or product is required for transfusion) | null | null | Assign this code for each processed blood unit |
732500380 | 73250-03-80 | Unlist blood bank proc | Unlisted blood bank procedure (transfusion procedure) | 21 | Laboratory and Pathology | 3,250 | Blood Screening & Transfusion related Procedures | Unlisted or unspecified transfusion/blood bank procedure | null | null | null |
733000001 | 73300-00-01 | Acetaminophen; Quant. | Quantitative measurement of drug Acetaminophen Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Acetaminophen quantification (analgesic; pain reliever/fever reducer) | null | null | null |
733000002 | 73300-00-02 | Adalimumab; Quant. | Quantitative measurement of drug Adalimumab Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Adalimumab quantification [analgesic (TNF; immune conditions associated] | null | null | Do not assign this code to Adalimumab Antibodies (atA), instead use (Unlisted Substances Immunoassay) |
733000003 | 73300-00-03 | Amiodarone; Quant. | Quantitative measurement of drug Amiodarone Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Amiodarone quantification (antrhythmic; irregular heartbeat) | null | null | null |
733000031 | 73300-00-31 | Carbamazepine ; -10 11-epoxide; Quant. | Quantitative measurement of drug Carbamazepine (-10,11-epoxide) Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Carbamazepine quantification (anticonvulsant) | null | null | Can be reported in addition to total or free Carbamazepine test, when performed. |
733000111 | 73300-01-11 | Felbamate; Quant. | Quantitative measurement of drug Felbamate Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Felbamate quantification (seizures) | null | null | null |
733000112 | 73300-01-12 | Flecainide; Quant. | Quantitative measurement of drug Flecainide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Flecainide quantification (antiarrhythmic medication) | null | null | null |
733000141 | 73300-01-41 | Hydroxychloroquine; Quant. | Quantitative measurement of drug Hydroxychloroquine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Hydroxychloroquine quantification (autoimmune conditions; RA, LUPUS, MALARIA) | null | null | null |
733000142 | 73300-01-42 | Infliximab; Quant. | Quantitative measurement of drug Infliximab Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Infliximab quantification (TNF; immune related) | INFLIIMAB ABS | null | null |
733000143 | 73300-01-43 | Itraconazole; Quant. | Quantitative measurement of drug Itraconazole Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Itraconazole quantification (fungal infection) | null | null | null |
733000144 | 73300-01-44 | Lacosamide; Quant. | Quantitative measurement of drug Lacosamide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Lacosamide quantification (antiepileptic; seizures) | null | null | null |
733000151 | 73300-01-51 | Leflunomide; Quant. | Quantitative measurement of drug Leflunomide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Leflunomide quantification (DMARDs; RA) | null | null | null |
733000181 | 73300-01-81 | Salicylate; Quant. | Quantitative measurement of drug Salicylate (Asprin) Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Salicylate quantification (nonsteroidal anti–inflammatory drug (NSAID) | null | null | null |
733000182 | 73300-01-82 | Methotrexate; Quant. | Quantitative measurement of drug Methotrexate Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Methotrexate quantification (e.g. neoplasms) | null | null | null |
733000231 | 73300-02-31 | Posaconazole; Quant. | Quantitative measurement of drug Posaconazole Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Posaconazole quantification (e.g. Aspergillus/Candida infections) | null | null | null |
733000271 | 73300-02-71 | Rufinamide; Quant. | Quantitative measurement of drug Rufinamide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Rufinamide quantification (e.g. seizures) | null | null | null |
733000291 | 73300-02-91 | Theophylline; Quant. | Quantitative measurement of drug Theophylline Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Theophylline quantification (e.g. chronic lung conditions) | null | null | null |
733000341 | 73300-03-41 | Vedolizumab; Quant. | Quantitative measurement of drug Vedolizumab Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Vedolizumab quantification (e.g. gastrointestinal autoimmune ) | null | null | null |
733000342 | 73300-03-42 | Voriconazole; Quant. | Quantitative measurement of drug Voriconazole Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Voriconazole quantification (e.g. fungal infections) | null | null | null |
733000435 | 73300-04-35 | Alkaloids; Quant./Qual. | Quantitative/Qualitative measurement of Alkaloids | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Alkaloids identification (e.g. initial drug abuse screen) | null | null | null |
733000865 | 73300-08-65 | Phencyclidine; Quant./Qual. | Quantitative/Qualitative measurement of Phencyclidine (PCP) | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Phencyclidine (PCP) identification (e.g. overdose) | null | null | null |
733000000 | 73300-00-00 | Amikacin; Quant. | Quantitative measurement of drug Amikacin Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Amikacin quantification (antibiotic; bacterial infections) | null | null | null |
733000010 | 73300-00-10 | Caffeine; Quant. | Quantitative measurement of drug Caffeine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Caffeine quantification (neonatal apnea ) | null | null | null |
733000020 | 73300-00-20 | Carbamazepine ; Total; Quant. | Quantitative measurement of drug Carbamazepine Total Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Total Carbamazepine quantification (epilepsy) | null | null | When both free and total Carbamazepine tests are ordered, assign both codes. |
733000030 | 73300-00-30 | Carbamazepine ; Free; Quant. | Quantitative measurement of drug Carbamazepine Free Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Free Carbamazepine quantification (e.g. kidney disease) | null | null | When both free and total Carbamazepine tests are ordered, assign both codes. |
733000040 | 73300-00-40 | Cyclosporine; Quant. | Quantitative measurement of drug Cyclosporine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cyclosporine quantification (immunosuppressant) | null | null | null |
733000050 | 73300-00-50 | Clozapine; Quant. | Quantitative measurement of drug Clozapine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cyclosporine quantification (antipsychotic) | null | null | null |
733000060 | 73300-00-60 | Digoxin (Total); Quant. | Quantitative measurement of drug Digoxin Total Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Digoxin quantification (congestive heart failure, slow HR) | null | null | null |
733000070 | 73300-00-70 | Digoxin ; Free; Quant. | Quantitative measurement of drug Digoxin Free Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Digoxin quantification (congestive heart failure, slow HR) | null | null | null |
733000080 | 73300-00-80 | Valproic Acid (Total); Quant. | Quantitative measurement of drug Valproic Acid (dipropylacetic acid) Total Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Valproic Acid quantification (seizures) | null | null | null |
733000090 | 73300-00-90 | Valproic Acid; Free; Quant. | Quantitative measurement of drug Valproic Acid (dipropylacetic acid) Free Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Valproic Acid quantification (seizures) | null | null | null |
733000100 | 73300-01-00 | Ethosuximide; Quant. | Quantitative measurement of drug Ethosuximide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Ethosuximide quantification (anticonvulsant/seizure) | null | null | null |
733000110 | 73300-01-10 | Everolimus; Quant. | Quantitative measurement of drug Everolimus Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Everolimus quantification (Immunosuppressant; prevent organ rejection ) | null | null | null |
733000120 | 73300-01-20 | Gentamicin; Quant. | Quantitative measurement of drug Gentamicin Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Gentamicin quantification (antibiotic medication) | null | null | null |
733000130 | 73300-01-30 | Gabapentin; Quant. | Quantitative measurement of drug Gabapentin Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Gabapentin quantification (seizures) | null | null | null |
733000140 | 73300-01-40 | Haloperidol; Quant. | Quantitative measurement of drug Haloperidol Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Haloperidol quantification (antipsychotic) | null | null | null |
733000150 | 73300-01-50 | Lamotrigine; Quant. | Quantitative measurement of drug Lamotrigine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Lamotrigine quantification (bipolar; seizures) | null | null | null |
733000160 | 73300-01-60 | Lidocaine; Quant. | Quantitative measurement of drug Lidocaine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Lidocaine quantification (arrhythmias) | null | null | null |
733000170 | 73300-01-70 | Levetiracetam; Quant. | Quantitative measurement of drug Levetiracetam Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Levetiracetam quantification (seizures; renal disease) | null | null | null |
733000180 | 73300-01-80 | Lithium; Quant. | Quantitative measurement of drug Lithium Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Lithium quantification (manic depressive disorders) | null | null | null |
733000190 | 73300-01-90 | Mycophenolate; Quant. | Quantitative measurement of drug Mycophenolate (mycophenolic acid) Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Mycophenolic acid quantification (e.g. monitor immunosuppressants in transplant patients ) | null | null | null |
733000200 | 73300-02-00 | Oxcarbazepine; Quant. | Quantitative measurement of drug Oxcarbazepine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Oxcarbazepine quantification (e.g. seizure) | null | null | null |
733000210 | 73300-02-10 | Phenobarbital; Quant. | Quantitative measurement of drug Phenobarbital Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Phenobarbital quantification (anticonvulsant) | null | null | null |
733000220 | 73300-02-20 | Phenytoin (Total); Quant. | Quantitative measurement of drug Phenytoin Total Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Phenytoin quantification (anticonvulsant) | null | null | null |
733000230 | 73300-02-30 | Phenytoin ; Free; Quant. | Quantitative measurement of drug Phenytoin Free Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Phenytoin quantification (anticonvulsant) | null | null | null |
733000240 | 73300-02-40 | Primidone; Quant. | Quantitative measurement of drug Primidone Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Primidone quantification (e.g. anticonvulsant) | null | null | null |
733000250 | 73300-02-50 | Procainamide; Quant. | Quantitative measurement of drug Procainamide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Procainamide quantification (e.g. Arrhythmias) | null | null | null |
733000260 | 73300-02-60 | Procainamide ; w/Metabolites; Quant. | Quantitative measurement of drug Procainamide Levels with presence of metabolites (e.g. N-acetyl procainamide) | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Procainamide quantification (e.g. Arrhythmias) | null | null | null |
733000270 | 73300-02-70 | Quinidine; Quant. | Quantitative measurement of drug Quinidine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Quinidine quantification (e.g. arrhythmias) | null | null | null |
733000280 | 73300-02-80 | Sirolimus; Quant. | Quantitative measurement of drug Sirolimus (rapamycin) Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Rapamycin quantification (e.g. prevents organ transplant rejection) | null | null | null |
733000290 | 73300-02-90 | Tacrolimus; Quant. | Quantitative measurement of drug Tacrolimus Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tacrolimus quantification (e.g. immunosuppressant to prevent organ transplant rejection) | null | null | null |
733000300 | 73300-03-00 | Dimethylxanthine; Quant. | Quantitative measurement of drug Dimethylxanthine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Dimethylxanthine quantification | null | null | null |